Le Lézard
Classified in: Health, Business
Subject: SVY

Fully Insured Health Plans Saw Top Line Growth but Shrinking Profit Margins in the ACA Era, New Deloitte Study Reveals


NEW YORK, Dec. 4, 2017 /PRNewswire/ -- As fully insured health plans emerge from six years of continued policy and market turbulence surrounding the Affordable Care Act (ACA), financial data analysis indicates a mixed financial performance. Two hundred and thirty-eight U.S. fully insured health plans experienced significant revenue increases over the past six years, though those gains were tempered by declining margins and growing underwriting losses. That was one of several important findings from a new "Health Plan Financial Trends 2011-2016" study by the Deloitte Center for Health Solutions. It is first of a series looking at the U.S. fully insured plans market.

As used in this document, "Deloitte" means Deloitte LLP. Please see  www.deloitte.com/us/about for a detailed description of the legal structure of Deloitte LLP and its subsidiaries. Certain services may not be available to attest clients under the rules and regulations of public accounting. (PRNewsFoto/Deloitte)

"A key takeaway is: While the three largest plans accounted for a large portion of the total underwriting gain in the industry, there is a strikingly large number of smaller players with more challenging financials. They hover in the uncomfortable zone right around breaking even," said Greg Scott, principal, Deloitte Consulting LLP, and U.S. health plan leader.

Key findings
The Deloitte study found that fully insured health plan revenue increased 55 percent between 2011 and 2016, with enrollment also increasing from 143 million to 184 million members. But underwriting gains in 2016 were 29 percent below 2011 results.

The industry also saw a significant increase in the number of plans with annual losses, a steep decline in average margins, and widening performance variation among plans. These unfavorable trends emerged largely in 2014, the initial year of major coverage expansions under the ACA.

Another important discovery was that the largest national health plans captured a disproportionate, and growing, share of all underwriting gains. Their margin share was due in part to the number and magnitude of losses suffered by other health plans, particularly in ACA commercial individual products.   

The study also found that for-profit health plans grew faster and posted significantly higher margins than not-for-profit health plans. For-profit plans saw revenue jump by 60 percent between 2011 and 2016, while not-for-profit plans had a revenue increase of 49 percent during the same period. For-profit plans had an average margin in 2016 of 2.5; the non-profit margin was 0.8 percent in 2016.  

Lastly, the study revealed state insurance markets experienced increased volatility. There was a marked increase in the number and variety of states with unfavorable swings in insurance market performance, with the performance of health insurance markets in many states deteriorating significantly.

What's next
This fully insured health plan study is the first installment in a series of Deloitte reports on health plan financial trends. Future installments in this series will also examine government-sponsored health insurance market trends, as well as trends in the commercial group and commercial individual segments.

To access the first installment of this series, on overall fully insured health plan trends, please visit the Deloitte website.

About Deloitte
Deloitte provides industry-leading audit, consulting, tax and advisory services to many of the world's most admired brands, including more than 85 percent of the Fortune 500 and more than 6,000 private and middle market companies. Our people work across more than 20 industry sectors to make an impact that matters ? delivering measurable and lasting results that help reinforce public trust in our capital markets, inspire clients to see challenges as opportunities to transform and thrive, and help lead the way toward a stronger economy and a healthy society. Deloitte is proud to be part of the largest global professional services network serving our clients in the markets that are most important to them. 

Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee ("DTTL"), its network of member firms, and their related entities. DTTL and each of its member firms are legally separate and independent entities. DTTL (also referred to as "Deloitte Global") does not provide services to clients. In the United States, Deloitte refers to one or more of the US member firms of DTTL, their related entities that operate using the "Deloitte" name in the United States and their respective affiliates. Certain services may not be available to attest clients under the rules and regulations of public accounting. Please see www.deloitte.com/about to learn more about our global network of member firms.

SOURCE Deloitte


These press releases may also interest you

at 10:50
NOTE: The new presentation time for Aurinia's presentation at the 2024 Bloom Burton & Co. Healthcare Investor Conferences is 4:00 to 4:30 PM Eastern Time. This event is presentation only. Webcast Details remain the same. The updated release reads:...

at 10:50
The following statement can be attributed to Joe Panetta, Biocom California's president and CEO, and Kendalle Burlin O'Connell, Massachusetts Biotechnology Council's (MassBio) CEO and president. "We strongly support efforts to continue American...

at 10:44
Theradaptive, the market leader in targeted regenerative therapeutics, today announced the expansion of its senior leadership team with the appointment of Dr. Frank Vizesi, Ph.D. as Chief Scientific Officer....

at 10:34
Olympus, a leading global medtech company providing innovative solutions for medical and surgical procedures, announced today positive changes to commercial payer policies covering patients who could benefit from the iTindtm procedure, a minimally...

at 10:30
"I wanted to create a protective covering that can be used with any public seating," said an inventor, from Cerritos, Calif., "so I invented the TRANSIT SEAT PAD. My design eliminates the need to wipe seats or find a cleaner seat to use."...

at 10:24
The global influenza vaccine market  size is estimated to grow by USD 2933.88 mn from 2023-2027, according to Technavio. The market is estimated to grow at a CAGR of  6.89%  during the forecast period.  The global influenza vaccine market is...



News published on and distributed by: